BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 38460398)

  • 1. Rates of Downstream Procedures and Complications Associated With Lung Cancer Screening in Routine Clinical Practice : A Retrospective Cohort Study.
    Rendle KA; Saia CA; Vachani A; Burnett-Hartman AN; Doria-Rose VP; Beucker S; Neslund-Dudas C; Oshiro C; Kim RY; Elston-Lafata J; Honda SA; Ritzwoller D; Wainwright JV; Mitra N; Greenlee RT
    Ann Intern Med; 2024 Jan; 177(1):18-28. PubMed ID: 38163370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Utilization of Low-Dose CT for Lung Cancer Screening at an Arkansas Community Oncology Clinic.
    Ellis ET; Bauer MA; Beck JT; Bradford DS; Thompson J; Holt A; Kulik MC; Stahr SD; Hsu PC; Su LJ
    J Am Coll Radiol; 2024 Jun; 21(6):858-866. PubMed ID: 37984767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Equitable implementation of lung cancer screening: avoiding its potential to mirror existing inequities among people who use tobacco.
    Bilenduke E; Anderson S; Brenner A; Currier J; Eberth JM; King J; Land SR; Risendal BC; Shannon J; Siegel LN; Wangen M; Waters AR; Zahnd WE; Studts JL
    Cancer Causes Control; 2023 Dec; 34(Suppl 1):209-216. PubMed ID: 37713024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with adherence to provider referrals for lung cancer screening with low dose computed tomography before and during COVID-19 pandemic.
    Li J; Stults CD; Liang SY; Martinez M
    BMC Cancer; 2023 Aug; 23(1):809. PubMed ID: 37644406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study.
    Li N; Tan F; Chen W; Dai M; Wang F; Shen S; Tang W; Li J; Yu Y; Cao W; Xu Y; Qin C; Zhao L; Zhu M; Guo L; Wu Z; Yang Z; Zheng Y; Chen H; Liu Y; Wei D; Dong D; Cao J; Zhang S; Yan S; Wang N; Du L; Shen H; Wu N; He J;
    Lancet Respir Med; 2022 Apr; 10(4):378-391. PubMed ID: 35276087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lung cancer screening in urban Beijing from 2014 to 2019].
    Yang L; Zhang X; Liu S; Li HC; Li QY; Wang N; Ji JF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Mar; 55(3):339-345. PubMed ID: 33730825
    [No Abstract]   [Full Text] [Related]  

  • 7. Hospitalization as an opportunity to improve lung cancer screening in high-risk patients.
    Nielsen EM; Zhang J; Marsden J; Bays C; Moran WP; Mauldin PD; Lenert LA; Toll BA; Schreiner AD; Heincelman M
    Cancer Epidemiol; 2024 Jun; 90():102553. PubMed ID: 38460398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality.
    Bonney A; Malouf R; Marchal C; Manners D; Fong KM; Marshall HM; Irving LB; Manser R
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD013829. PubMed ID: 35921047
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.